Summit Therapeutics (SMMT) operating margin

Operating margin · fiscal 2022
-9024.3%

Summit Therapeutics (SMMT) had an operating margin of -9024.3% in fiscal 2022 (the year ended December 31, 2022). That is 4260.0 percentage points lower than the -4764.3% of fiscal 2021. Figures as of 17 Nov 2026, 21:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2022
-9024.3%
Change on fiscal 2021
−4260.0 pts
Highest on record
9.4%fiscal 2019
Lowest on record
-9024.3%fiscal 2022
Fiscal years on record
42019–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Summit Therapeutics operating margin, in more detail

Across the 4 fiscal years on record (2019–2022), the highest was 9.4% in fiscal 2019 and the lowest -9024.3% in fiscal 2022. The fiscal 2022 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is -4764.3%.

Net margin was -11174.8% in fiscal 2022.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Summit Therapeutics operating margin, year by year

Summit Therapeutics (SMMT) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
2022-9024.3% 4260.0 pts down-11174.8%
2021-4764.3% 1420.9 pts up-4897.8%
2020-6185.2% 6194.7 pts down-6127.6%
20199.4%—19.0%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Summit Therapeutics and comparable companies
CompanyOperating marginFiscal year
BridgeBio Pharma BBIO-100.0%2025
Summit Therapeutics SMMT-9024.3%2022
Glaukos GKOS-39.3%2025
Encompass Health EHC17.7%2025
BrightSpring Health Services BTSG2.3%2025
Baxter International BAX1.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SMMT

Summit Therapeutics, figure by figure

Summit Therapeutics (SMMT) overview: price, valuation and scorecardAll health care companies by market value

Summit Therapeutics operating margin: questions and answers

What is Summit Therapeutics's operating margin?

Summit Therapeutics (SMMT) had an operating margin of -9024.3% in fiscal 2022 (the year ended December 31, 2022). That is 4260.0 percentage points lower than the -4764.3% of fiscal 2021.

Is Summit Therapeutics's operating margin high or low compared with its own history?

The fiscal 2022 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is -4764.3%.

What are the highest and lowest operating margin figures on record for Summit Therapeutics?

Across the 4 fiscal years on record (2019–2022), the highest was 9.4% in fiscal 2019 and the lowest -9024.3% in fiscal 2022.

What are Summit Therapeutics's gross and net margins?

Net margin was -11174.8% in fiscal 2022.

How is Summit Therapeutics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Summit Therapeutics (SMMT) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/SMMT/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.